A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients

被引:48
|
作者
Silva, I. [1 ]
Almeida, J. [2 ]
Vasconcelos, C. [3 ,4 ]
机构
[1] Hosp Santo Antonio, Clin Imunol Unit, Ctr Hosp Porto, P-4150789 Oporto, Portugal
[2] Ctr Hosp Vila Nova de Gaia, Internal Med Serv, Vila Nova De Gaia, Portugal
[3] Hosp Santo Antonio, Ctr Hosp Porto, Clin Imunol Unit, P-4150789 Oporto, Portugal
[4] Univ Porto, UMIB, ICBAS, P-4100 Oporto, Portugal
关键词
Digital ulcer/s; Systemic sclerosis; Autoantibodies; Endothelin-1; Vascular endothelial growth factor (VEGF); C.apillaroscopy; ENDOTHELIAL GROWTH-FACTOR; ANTIENDOTHELIAL CELL ANTIBODIES; SEVERE ORGAN INVOLVEMENT; VON-WILLEBRAND-FACTOR; NAILFOLD CAPILLAROSCOPY; CLINICAL-FEATURES; SCLERODERMA PATIENTS; RAYNAUDS-PHENOMENON; VASCULAR-DISEASE; I ANTIBODIES;
D O I
10.1016/j.autrev.2014.10.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vasculopathy has a major role in the pathogenesis and tissue injury in systemic sclerosis (SSc). Raynaud's phenomenon (RP) is frequently the first clinical manifestation of SSc preceding by years other clinical manifestations. RP in SSc patients is frequent, often very severe and long lasting. The repeated bouts of RP lead to prolonged digital ischemia that may progress to digital ulceration or in extreme to critical digital ischemia with gangrene. Digital ulcers (DU) are a true burden for all patients. They are very painful, with a long and slow healing course, have high risk of infection and are extremely disabling. In adults, up to 40-50% of patients will experience at least one DU in the course of the disease and of these 31-71% will have recurrent ulcers. In order to try to identify predictive risk factors for DU in SSc patients, an extensive literature review was conducted, according to the guidelines proposed at the PRISMA statement. MEDLINE database (PubMed) and Thomson Reuters Web of Knowledge platform were searched for articles published in peer-reviewed journals since 1990 with the last search run on June 2014 and published in English language. The keyword search terms included: digital ulcer/s, systemic sclerosis, scleroderma, digital scars, ischemic complications, autoantibodies, biomarkers, endothelium dysfunction, endothelin-1, vascular endothelial growth factor (VEGF), endostatin, ADMA, endoglin, angiostatin, and capillaroscopy. The following criteria were included: (1) cohorts of SSc patients including patients with DU, (2) endothelium dysfunction and angiogenesis biomarkers compared with a healthy control group, (3) autoantibodies, capillary morphology and distribution, endothelium dysfunction and angiogenesis biomarkers compared between patients with and without digital ulcers, (4) detailed description of the statistical methods used to conclude for predictive factors, and (5) English language. Our search provided a total of 376 citations. Of these, 297 studies were discarded for not meeting the criteria proposed. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:140 / 152
页数:13
相关论文
共 50 条
  • [41] Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review
    Campochiaro, Corrado
    Suliman, Yossra A.
    Hughes, Michael
    Schoones, Jan W.
    Giuggioli, Dilia
    Moinzadeh, Pia
    Baron, Murray
    Chung, Lorinda
    Ross, Laura
    Maltez, Nancy
    Allanore, Yannick
    Denton, Christopher P.
    Distler, Oliver
    Frech, Tracy
    Furst, Daniel E.
    Khanna, Dinesh
    Krieg, Thomas
    Kuwana, Masataka
    Matucci-Cerinic, Marco
    Pope, Janet
    Alunno, Alessia
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [42] NON-SURGICAL LOCAL TREATMENTS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: A SYSTEMATIC LITERATURE REVIEW
    Campochiaro, C.
    Suliman, Y. A.
    Hughes, M.
    Schoones, J.
    Giuggioli, D.
    Moinzadeh, P.
    Maltez, N.
    Ross, L.
    Baron, M.
    Chung, L.
    Allanore, Y.
    Denton, C. P.
    Distler, O.
    Frech, T.
    Furst, D.
    Khanna, D.
    Krieg, T.
    Kuwana, M.
    Matucci-Cerinic, M.
    Pope, J.
    Alunno, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 740 - 741
  • [43] Geographic variation as a risk factor for digital ulcers in systemic sclerosis patients: a multicentre registry
    Souza, E. J. R.
    Muller, C. S.
    Horimoto, A. M. C.
    Rezende, R. A.
    Guimaraes, I.
    Mariz, H. A.
    Dantas, A. T.
    Da Costa, I. P.
    Del-Rio, A. P. T.
    Sekiyama, J.
    Kahwage, C. B.
    Kayser, C.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (04) : 288 - 295
  • [44] Skin ulcers in systemic sclerosis: Determinants of presence and predictive factors of healing
    Alivernini, Stefano
    De Santis, Maria
    Tolusso, Barbara
    Mannocci, Alice
    Bosello, Silvia Laura
    Peluso, Giusy
    Pinnelli, Michela
    D'Antona, Graziella
    LaTorre, Giuseppe
    Ferraccioli, Gianfranco
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : 426 - 435
  • [45] Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
    Chiara Pellicano
    Giorgia Leodori
    Amalia Colalillo
    Luca Navarini
    Antonietta Gigante
    Edoardo Rosato
    Clinical and Experimental Medicine, 2022, 22 : 421 - 426
  • [46] Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
    Pellicano, Chiara
    Leodori, Giorgia
    Colalillo, Amalia
    Navarini, Luca
    Gigante, Antonietta
    Rosato, Edoardo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 22 (03) : 421 - 426
  • [47] Health Care Utilization in Systemic Sclerosis Patients With Digital Ulcers
    Nevskaya, Tatiana
    Calderon, Leonardo M.
    Baron, Murray
    Pope, Janet E.
    ARTHRITIS CARE & RESEARCH, 2023, 75 (05) : 1071 - 1078
  • [48] THE PREVALENCE OF OSTEOMYELITIS IN INFECTED DIGITAL ULCERS IN SYSTEMIC SCLEROSIS PATIENTS
    Braun-Moscovici, Y.
    Keidar, Z.
    Braun, M.
    Markovits, D.
    Toledano, K.
    Tavor, Y.
    Sabbah, F.
    Rozin, A.
    Dolnikov, K.
    Balbir-Gurman, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 910 - 910
  • [49] Bosentan for treatment of active digital ulcers in patients with systemic sclerosis
    Launay, D
    Diot, É
    Pasquier, É
    Mouthon, L
    Boullanger, N
    Fain, O
    Jego, P
    Carpentier, P
    Hatron, PY
    Hachulla, É
    PRESSE MEDICALE, 2006, 35 (04): : 587 - 592
  • [50] BOSENTAN FOR DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS: SINGLECENTER EXPERIENCE
    Kucuksahin, O.
    Ates, A.
    Ilgrn, U.
    Ozturk, B.
    Kinikli, G.
    Turgay, M.
    Duzgun, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S79 - S79